Search research articles
Contact Us
Filters
Showing results (21-30 of 25) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 25 results.
The Journal of Experimental Medicine
|
August 8, 2001
NTB-A [correction of GNTB-A], a novel SH2D1A-associated surface molecule contributing to the inability of natural killer cells to kill Epstein-Barr virus-infected B cells in X-linked lymphoproliferative disease
C Bottino, M Falco, S Parolini, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
March 1, 1997
Basic fibroblast growth factor-induced angiogenic phenotype in mouse endothelium. A study of aortic and microvascular endothelial cell lines
M Bastaki, E E Nelli, P Dell'Era, et al.
The Journal of Experimental Medicine
|
November 24, 1999
Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells
D Pende, S Parolini, A Pessino, et al.
The Journal of Experimental Medicine
|
August 10, 2000
X-linked lymphoproliferative disease. 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells
S Parolini, C Bottino, M Falco, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research
|
February 1, 1996
Basic fibroblast growth factor overexpression in endothelial cells: an autocrine mechanism for angiogenesis and angioproliferative diseases
A Gualandris, M Rusnati, M Belleri, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 25) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 25 results.
The Journal of Experimental Medicine
|
August 8, 2001
NTB-A [correction of GNTB-A], a novel SH2D1A-associated surface molecule contributing to the inability of natural killer cells to kill Epstein-Barr virus-infected B cells in X-linked lymphoproliferative disease
C Bottino, M Falco, S Parolini, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
March 1, 1997
Basic fibroblast growth factor-induced angiogenic phenotype in mouse endothelium. A study of aortic and microvascular endothelial cell lines
M Bastaki, E E Nelli, P Dell'Era, et al.
The Journal of Experimental Medicine
|
November 24, 1999
Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells
D Pende, S Parolini, A Pessino, et al.
The Journal of Experimental Medicine
|
August 10, 2000
X-linked lymphoproliferative disease. 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells
S Parolini, C Bottino, M Falco, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research
|
February 1, 1996
Basic fibroblast growth factor overexpression in endothelial cells: an autocrine mechanism for angiogenesis and angioproliferative diseases
A Gualandris, M Rusnati, M Belleri, et al.
Page
of 3